Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Dotis, J., Pana Z. Dorothea, & Roilides E. (2013).  Non-Aspergillus fungal infections in chronic granulomatous disease.. Mycoses. 56(4), 449-62.
Emeriewen, K., Kadare S., Tsatsos M., Athanasiadis Y., MacGregor C., & Rassam S. (2016).  Non-arteritic Anterior Ischaemic Optic Neuropathy after Uneventful Cataract Extraction.. Neuroophthalmology. 40(5), 225-228.
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Pafili, K., Paschou S. A., Armeni E., Polyzos S. A., Goulis D. G., & Lambrinoudaki I. (2022).  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.. J Endocrinol Invest.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.. Curr Mol Med. 9(3), 299-314.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.. J Clin Gastroenterol. 46(4), 272-84.
Vachliotis, I., Goulas A., Papaioannidou P., & Polyzos S. A. (2021).  Nonalcoholic fatty liver disease: lifestyle and quality of life.. Hormones (Athens).
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Macut, D., Tziomalos K., Božić-Antić I., Bjekić-Macut J., Katsikis I., Papadakis E., et al. (2016).  Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.. Hum Reprod. 31(6), 1347-53.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2012).  Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.. Curr Vasc Pharmacol. 10(2), 162-72.
Polyzos, S. A., Mousiolis A., Mintziori G., & Goulis D. G. (2020).  Nonalcoholic fatty liver disease in males with low testosterone concentrations.. Diabetes Metab Syndr. 14(5), 1571-1577.
Muzurović, E., Polyzos S., Mikhailidis D., Borozan S., Novosel D., Cmiljanić O., et al. (2022).  Non-alcoholic fatty liver disease in children.. Curr Vasc Pharmacol.
Tziomalos, K., Athyros V. G., Paschos P., & Karagiannis A. (2015).  Nonalcoholic fatty liver disease and statins.. Metabolism. 64(10), 1215-23.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.. Angiology. 64(8), 572-5.
Polyzos, S. A., Goulis D. G., & Kountouras J. (2015).  Nonalcoholic fatty liver disease and polycystic ovary syndrome.. Ann Hepatol. 14(6), 941-3.
Vachliotis, I. D., Anastasilakis A. D., Goulas A., Goulis D. G., & Polyzos S. A. (2022).  Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.. Diabetes Obes Metab. 24(9), 1702-1720.
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
Polyzos, S. A., & Kountouras J. (2023).  Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?. Curr Vasc Pharmacol.
Papagianni, M., & Tziomalos K. (2018).  Non-alcoholic fatty liver disease: an emerging predictor of stroke risk, severity and outcome.. Eur J Neurol. 25(4), 610-611.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές